1 Duloxetine Active Pharmaceutical Ingredients (API) Market Overview 1.1 Product Overview and Scope of Duloxetine Active Pharmaceutical Ingredients (API) 1.2 Duloxetine Active Pharmaceutical Ingredients (API) Segment by Type 1.2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Major Depression Drug 1.2.3 Generalized Anxiety Disorder Drug 1.2.4 Fibromyalgia Drugs 1.2.5 Neuropathic Pain Medication 1.2.6 Other 1.3 Duloxetine Active Pharmaceutical Ingredients (API) Segment by Application 1.3.1 Duloxetine Active Pharmaceutical Ingredients (API) Sales Comparison by Application: (2021-2027) 1.3.2 Pharmaceutical and Biotechnology Industries 1.3.3 Hospital 1.3.4 Other 1.4 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts 1.4.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue 2016-2027 1.4.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales 2016-2027 1.4.3 Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Duloxetine Active Pharmaceutical Ingredients (API) Market Competition by Manufacturers 2.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Manufacturing Sites, Area Served, Product Type 2.5 Duloxetine Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends 2.5.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Duloxetine Active Pharmaceutical Ingredients (API) Players Market Share by Revenue 2.5.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Duloxetine Active Pharmaceutical Ingredients (API) Retrospective Market Scenario by Region 3.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country 3.3.1 North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country 3.3.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country 3.4.1 Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country 3.4.2 Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Region 3.5.1 Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region 3.5.2 Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country 3.6.1 Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country 3.6.2 Latin America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country 3.7.1 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country 3.7.2 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Duloxetine Active Pharmaceutical Ingredients (API) Historic Market Analysis by Type 4.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021) 4.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021) 4.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2016-2021) 5 Global Duloxetine Active Pharmaceutical Ingredients (API) Historic Market Analysis by Application 5.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021) 5.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2021) 5.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Teva Pharmaceutical Industries Ltd (Israel) 6.1.1 Teva Pharmaceutical Industries Ltd (Israel) Corporation Information 6.1.2 Teva Pharmaceutical Industries Ltd (Israel) Description and Business Overview 6.1.3 Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Teva Pharmaceutical Industries Ltd (Israel) Product Portfolio 6.1.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Developments/Updates 6.2 Sun Pharmaceutical Industries Ltd (India) 6.2.1 Sun Pharmaceutical Industries Ltd (India) Corporation Information 6.2.2 Sun Pharmaceutical Industries Ltd (India) Description and Business Overview 6.2.3 Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sun Pharmaceutical Industries Ltd (India) Product Portfolio 6.2.5 Sun Pharmaceutical Industries Ltd (India) Recent Developments/Updates 6.3 Aurobindo Pharma (India) 6.3.1 Aurobindo Pharma (India) Corporation Information 6.3.2 Aurobindo Pharma (India) Description and Business Overview 6.3.3 Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Aurobindo Pharma (India) Product Portfolio 6.3.5 Aurobindo Pharma (India) Recent Developments/Updates 6.4 Lupin (India) 6.4.1 Lupin (India) Corporation Information 6.4.2 Lupin (India) Description and Business Overview 6.4.3 Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Lupin (India) Product Portfolio 6.4.5 Lupin (India) Recent Developments/Updates 6.5 Zydus Cadila (India) 6.5.1 Zydus Cadila (India) Corporation Information 6.5.2 Zydus Cadila (India) Description and Business Overview 6.5.3 Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Zydus Cadila (India) Product Portfolio 6.5.5 Zydus Cadila (India) Recent Developments/Updates 6.6 Eli Lilly and Company (United States) 6.6.1 Eli Lilly and Company (United States) Corporation Information 6.6.2 Eli Lilly and Company (United States) Description and Business Overview 6.6.3 Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Eli Lilly and Company (United States) Product Portfolio 6.6.5 Eli Lilly and Company (United States) Recent Developments/Updates 6.7 Shodhana Laboratories (India) 6.6.1 Shodhana Laboratories (India) Corporation Information 6.6.2 Shodhana Laboratories (India) Description and Business Overview 6.6.3 Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Shodhana Laboratories (India) Product Portfolio 6.7.5 Shodhana Laboratories (India) Recent Developments/Updates 6.8 Hetero (India) 6.8.1 Hetero (India) Corporation Information 6.8.2 Hetero (India) Description and Business Overview 6.8.3 Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Hetero (India) Product Portfolio 6.8.5 Hetero (India) Recent Developments/Updates 6.9 Apotex (Canada) 6.9.1 Apotex (Canada) Corporation Information 6.9.2 Apotex (Canada) Description and Business Overview 6.9.3 Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Apotex (Canada) Product Portfolio 6.9.5 Apotex (Canada) Recent Developments/Updates 6.10 Shionogi (US) 6.10.1 Shionogi (US) Corporation Information 6.10.2 Shionogi (US) Description and Business Overview 6.10.3 Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Shionogi (US) Product Portfolio 6.10.5 Shionogi (US) Recent Developments/Updates 6.11 Zhejiang Huahai Pharmaceutical (China) 6.11.1 Zhejiang Huahai Pharmaceutical (China) Corporation Information 6.11.2 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Description and Business Overview 6.11.3 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Zhejiang Huahai Pharmaceutical (China) Product Portfolio 6.11.5 Zhejiang Huahai Pharmaceutical (China) Recent Developments/Updates 7 Duloxetine Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis 7.1 Duloxetine Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Duloxetine Active Pharmaceutical Ingredients (API) 7.4 Duloxetine Active Pharmaceutical Ingredients (API) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Duloxetine Active Pharmaceutical Ingredients (API) Distributors List 8.3 Duloxetine Active Pharmaceutical Ingredients (API) Customers 9 Duloxetine Active Pharmaceutical Ingredients (API) Market Dynamics 9.1 Duloxetine Active Pharmaceutical Ingredients (API) Industry Trends 9.2 Duloxetine Active Pharmaceutical Ingredients (API) Growth Drivers 9.3 Duloxetine Active Pharmaceutical Ingredients (API) Market Challenges 9.4 Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints 10 Global Market Forecast 10.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Duloxetine Active Pharmaceutical Ingredients (API) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Duloxetine Active Pharmaceutical Ingredients (API) by Type (2022-2027) 10.2 Duloxetine Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Duloxetine Active Pharmaceutical Ingredients (API) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Duloxetine Active Pharmaceutical Ingredients (API) by Application (2022-2027) 10.3 Duloxetine Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Duloxetine Active Pharmaceutical Ingredients (API) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Duloxetine Active Pharmaceutical Ingredients (API) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT) Comparison by Application (2021-2027) Table 3. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Covered in This Study Table 5. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2016-2021) Table 7. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Duloxetine Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Manufacturing Sites and Area Served Table 11. Manufacturers Duloxetine Active Pharmaceutical Ingredients (API) Product Type Table 12. Global Duloxetine Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Duloxetine Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duloxetine Active Pharmaceutical Ingredients (API) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (MT) Table 16. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021) Table 17. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (MT) Table 19. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021) Table 20. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021) Table 22. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (MT) Table 23. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021) Table 24. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021) Table 30. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (MT) Table 31. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021) Table 32. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021) Table 38. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT) by Type (2016-2021) Table 39. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021) Table 40. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Type (2016-2021) Table 41. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021) Table 42. Global Duloxetine Active Pharmaceutical Ingredients (API) Price (USD/MT) by Type (2016-2021) Table 43. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT) by Application (2016-2021) Table 44. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021) Table 45. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Application (2016-2021) Table 46. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Application (2016-2021) Table 47. Global Duloxetine Active Pharmaceutical Ingredients (API) Price (USD/MT) by Application (2016-2021) Table 48. Teva Pharmaceutical Industries Ltd (Israel) Corporation Information Table 49. Teva Pharmaceutical Industries Ltd (Israel) Description and Business Overview Table 50. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 52. Teva Pharmaceutical Industries Ltd (Israel) Recent Developments/Updates Table 53. Sun Pharmaceutical Industries Ltd (India) Corporation Information Table 54. Sun Pharmaceutical Industries Ltd (India) Description and Business Overview Table 55. Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 57. Sun Pharmaceutical Industries Ltd (India) Recent Developments/Updates Table 58. Aurobindo Pharma (India) Corporation Information Table 59. Aurobindo Pharma (India) Description and Business Overview Table 60. Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 62. Aurobindo Pharma (India) Recent Developments/Updates Table 63. Lupin (India) Corporation Information Table 64. Lupin (India) Description and Business Overview Table 65. Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 67. Lupin (India) Recent Developments/Updates Table 68. Zydus Cadila (India) Corporation Information Table 69. Zydus Cadila (India) Description and Business Overview Table 70. Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 72. Zydus Cadila (India) Recent Developments/Updates Table 73. Eli Lilly and Company (United States) Corporation Information Table 74. Eli Lilly and Company (United States) Description and Business Overview Table 75. Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 77. Eli Lilly and Company (United States) Recent Developments/Updates Table 78. Shodhana Laboratories (India) Corporation Information Table 79. Shodhana Laboratories (India) Description and Business Overview Table 80. Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 82. Shodhana Laboratories (India) Recent Developments/Updates Table 83. Hetero (India) Corporation Information Table 84. Hetero (India) Description and Business Overview Table 85. Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 87. Hetero (India) Recent Developments/Updates Table 88. Apotex (Canada) Corporation Information Table 89. Apotex (Canada) Description and Business Overview Table 90. Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 92. Apotex (Canada) Recent Developments/Updates Table 93. Shionogi (US) Corporation Information Table 94. Shionogi (US) Description and Business Overview Table 95. Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 97. Shionogi (US) Recent Developments/Updates Table 98. Zhejiang Huahai Pharmaceutical (China) Corporation Information Table 99. Zhejiang Huahai Pharmaceutical (China) Description and Business Overview Table 100. Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Product Table 102. Zhejiang Huahai Pharmaceutical (China) Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Duloxetine Active Pharmaceutical Ingredients (API) Distributors List Table 106. Duloxetine Active Pharmaceutical Ingredients (API) Customers List Table 107. Duloxetine Active Pharmaceutical Ingredients (API) Market Trends Table 108. Duloxetine Active Pharmaceutical Ingredients (API) Growth Drivers Table 109. Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints Table 110. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2022-2027) & (MT) Table 111. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type (2022-2027) Table 112. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 113. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Type (2022-2027) Table 114. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2022-2027) & (MT) Table 115. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Application (2022-2027) Table 116. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 117. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Application (2022-2027) Table 118. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2022-2027) & (MT) Table 119. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Region (2022-2027) Table 120. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 121. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Region (2022-2027) Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Duloxetine Active Pharmaceutical Ingredients (API) Figure 2. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Type in 2020 & 2027 Figure 3. Major Depression Drug Product Picture Figure 4. Generalized Anxiety Disorder Drug Product Picture Figure 5. Fibromyalgia Drugs Product Picture Figure 6. Neuropathic Pain Medication Product Picture Figure 7. Other Product Picture Figure 8. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Application in 2020 & 2027 Figure 9. Pharmaceutical and Biotechnology Industries Figure 10. Hospital Figure 11. Other Figure 12. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size 2016-2027 (US$ Million) Figure 14. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales 2016-2027 (MT) Figure 15. Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Duloxetine Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers in 2020 Figure 17. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Duloxetine Active Pharmaceutical Ingredients (API) Players: Market Share by Revenue in 2020 Figure 19. Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021) Figure 21. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2020 Figure 22. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021) Figure 23. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2020 Figure 24. U.S. Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Duloxetine Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Duloxetine Active Pharmaceutical Ingredients (API) by Type (2016-2021) Figure 49. Sales Market Share of Duloxetine Active Pharmaceutical Ingredients (API) by Application (2016-2021) Figure 50. Sales Market Share of Duloxetine Active Pharmaceutical Ingredients (API) by Application in 2020 Figure 51. Revenue Share of Duloxetine Active Pharmaceutical Ingredients (API) by Application (2016-2021) Figure 52. Revenue Share of Duloxetine Active Pharmaceutical Ingredients (API) by Application in 2020 Figure 53. Manufacturing Cost Structure of Duloxetine Active Pharmaceutical Ingredients (API) Figure 54. Manufacturing Process Analysis of Duloxetine Active Pharmaceutical Ingredients (API) Figure 55. Duloxetine Active Pharmaceutical Ingredients (API) Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Teva Pharmaceutical Industries Ltd (Israel) Sun Pharmaceutical Industries Ltd (India) Aurobindo Pharma (India) Lupin (India) Zydus Cadila (India) Eli Lilly and Company (United States) Shodhana Laboratories (India) Hetero (India) Apotex (Canada) Shionogi (US) Zhejiang Huahai Pharmaceutical (China)